CELEX: 62017CA0668
Language: en
Date: 2019-07-03 00:00:00
Title: Case C-668/17 P: Judgment of the Court (Fourth Chamber) of 3 July 2019 — Viridis Pharmaceutical Ltd. v European Union Intellectual Property Office (EUIPO), Hecht-Pharma GmbH (Appeal — European Union trade mark — Revocation proceedings — Word mark Boswelan — No genuine use — Use of the mark in a clinical trial prior to filing an application for authorisation to place a medicinal product on the market — Proper reason for non-use — Concept)

9.9.2019   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 305/8
            
         
      Judgment of the Court (Fourth Chamber) of 3 July 2019 — Viridis Pharmaceutical Ltd. v European Union Intellectual Property Office (EUIPO), Hecht-Pharma GmbH
      (Case C-668/17 P) (1)
      
      (Appeal - European Union trade mark - Revocation proceedings - Word mark Boswelan - No genuine use - Use of the mark in a clinical trial prior to filing an application for authorisation to place a medicinal product on the market - Proper reason for non-use - Concept)
      (2019/C 305/09)
      Language of the case: German
      
         Parties
      
      
         Appellant: Viridis Pharmaceutical Ltd. (represented by C. Spintig, S. Pietzcker and M. Prasse, Rechtsanwälte)
      
         Other parties to the proceedings: European Union Intellectual Property Office (EUIPO) (represented by S. Hanne, acting as Agent), Hecht-Pharma GmbH (represented by J. Sachs and C. Sachs, Rechtsanwälte)
      
         Operative part of the judgment
      
      The Court:
      
                  1.
               
               
                  Dismisses the action;
               
            
                  2.
               
               
                  Orders Viridis Pharmaceutical Ltd to pay, in addition to its own costs, those incurred by the European Union Intellectual Property Office (EUIPO) and Hecht-Pharma GmbH.
               
            
         (1)  OJ C 83, 5.3.2018.